Abstract 547: Generation of synthetic cytokine receptor-induced cytotoxic innate lymphocytes (iCILs) from iPSCs as off-the-shelf cancer therapeuticsSamantha O'Hara, Ryan Larson, Kristen Mittelsteadt et al.|Cancer Research|2022Cited by 0
ARMING INDUCED PLURIPOTENT STEM CELLS WITH A SYNTHETIC RECEPTOR PROMOTES MASSIVE PRODUCTION OF IMMUNE EFFECTOR CELLS CREATING THE POTENTIAL FOR "OFF-THE-SHELF" IMMUNOTHERAPIESA. Yingst, Shinya Ohara, D. Vereide et al.|Cytotherapy|2024Cited by 0
272 Arming pluripotent stem cell-derived lymphocytes with a suite of synthetic receptors enables scalable manufacturing and enhanced persistence and potency for potential off-the-shelf immunotherapyDillon K. Jarrell, Samantha DO’Hara, David Vereide et al.|Regular and Young Investigator Award Abstracts|2024Cited by 0
A Synthetic Receptor Enables Breakthrough Scale Manufacturing of iPSC-Derived CD19-CAR Cell Therapies for Hematologic and Autoimmune DiseasesDillon K. Jarrell, Samantha Ohara, David Vereide et al.|Blood|2024Cited by 0